Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Metrics Regulatory News (OMG)

Share Price Information for Oxford Metrics (OMG)

Share Price is delayed by 15 minutes
Get Live Data
46.50    0.50 (1.09%)
Bid:
46.50
Ask:
47.90
Spread: 1.40 (3.011%)
Market Cap: £52.05m
OMG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Metrics Share Chart

Contract Win

13 Jun 2008 07:00

RNS Number : 6369W
OMG PLC
13 June 2008
Β 

13Β June 2008

OMG plc

("OMG" or "the Group")

Contract Win

2d3 AIG securesΒ contract with Northrop Grumman Corporation

OMG plc, Oxford Metrics Group (LSE: OMG), the technology group providing image understanding products for the entertainment, defence, life science and engineering industries, is pleased to announce that the US arm of 2d3 AIG ("2d3"), the Group's defence business, has secured its first contract win in the United States.

Northrop Grumman Corporation ("NGC"), a keyΒ USΒ prime contractor for the US Department of Defense, has engaged 2d3Β on an evaluation contractΒ which, upon completion, willΒ prove 2d3's algorithmsΒ a critical componentΒ in allowing an Unmanned Aerial Vehicle ("UAV") to sense and avoid other aircraft using 2d3 proprietary technology.

Completion of theΒ contractΒ will see 2d3'sΒ algorithms evaluated for useΒ inΒ detectingΒ and trackingΒ other flying vehicles from an airborne camera, effectively allowing a UAV to see other aircraft much in the same way as a human pilot. TheΒ pilot project is valued at $100,000Β and will span a period of 6 months.

SuccessfulΒ resultsΒ will put 2d3 at the forefront of "Sense and Avoid" technology. This technology paves the way for UAVs to safely operate in US andΒ UKΒ national airspace alongside regular air traffic, opening up possible new markets for unmanned commercial aviation.

Today's announcement builds on the early success already enjoyed by 2d3 in theΒ UKΒ defence market where, in July and August 2007, the division succeeded in winning its first engagements with the UK Ministry of Defence.

Nick Bolton, Chief Executive Officer of OMG plc, added:

"This is a landmark contract for our 2d3 colleagues in theΒ US. Not only does this represent a significant endorsement of our technology and capability in the defence space, but it also vindicates our decision to establish our 2d3 US office back in June last year. I am particularly proud to be working with as prestigious an organisation as NorthropΒ GrummanΒ Corporation, which is at the forefront ofΒ USΒ defence technology. I hope that the delivery of a successful proof of concept here paves the way for further engagements for OMG in this key marketplace."

Contacts

OMG plc

+44 1865 261800

NickΒ Bolton, Chief Executive

Peter Wharton, Finance Director

Financial Dynamics

+44 20 7831 3113

Juliet Clarke / Matt Dixon

Evolution Securities

+44 20 7071 4300

Jeremy Ellis

Β Β Notes to Editors

About Northrop Grumman Corporation

Northrop Grumman Corporation is a $32 billion global defence and technology company whose 120,000 employees provide innovative systems, products, and solutions in information and services, electronics, aerospace and shipbuilding to government and commercial customers worldwide.

For further information on NGC, visitΒ www.northropgrumman.com.

Β 

About OMG

OMG plc (Oxford Metrics Group. LSE: OMG) is a group of technology companies producing image understanding products and services for the entertainment, defence, life science and engineering industries. Be it for capturing the movements of actors (for the movie industry), sportsmen (for video games or improving team performance), children with Cerebral Palsy, rehab patients and animals (for medical, life science and research industries) or virtual reality displays (for engineering and development), the Group has the world leading market position and a strong international reputation for precision instruments.

Β Founded in 1984, the Group's headquarters are inΒ Oxford,Β UK, and it has offices inΒ CaliforniaΒ andΒ Colorado,Β USA. It has customers in over 50 countries and is a quoted company listed on AIM, a market operated by the London Stock Exchange. The Group trades through three operating subsidiaries - Vicon, the world's biggest motion capture and movement analysis company, 2d3, a manufacturer of specialised image understanding software for entertainment and defence applications and Yotta, our 3D mapping business, which collects and analyses highway data and street level imaging and which, following the acquisition of Mobile Video Services,Β Inc. in April 2008 is aΒ leading US provider of data collection services for the assessment of property taxation.Β 

Oxford Metrics' global clients in science, medicine, sport, engineering, gaming, film, broadcast and 3D mapping include major hospitals and research facilities such as Guy's Hospital, Nuffield Orthopaedic Centre and Loughborough University, engineering industry leaders including Ford Motor Company, BMW, Airbus and Toyota, and in the entertainment sector, Sony, Industrial Light and Magic, The Moving Picture Company (MPC), Sega, Nintendo, UbiSoft, EA, Square Enix and in 3D mapping and highway surveys: Mouchel Parkman, Atkins, and Oxfordshire, Cumbria, Derbyshire and Pembrokeshire County Councils as well as many others.Β 

For more information about OMG and its subsidiaries, visitΒ www.omg3d.com,Β www.vicon.com,Β www.2d3.comΒ orΒ www.yotta.tv

-Ends-

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
CNTEASKDFLXPEEE
Date   Source Headline
2nd Jun 20264:20 pmRNSTotal Voting Rights
2nd Jun 20267:00 amRNSNotice of Results and Investor Event
21st May 20265:35 pmRNSCompletion of Buyback Programme
20th May 20267:00 amRNSTransaction in Own Shares
19th May 202610:07 amRNSNotification of Major Holdings
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20269:57 amRNSNotification of Major Holdings
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20263:19 pmRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 202611:26 amRNSNotification of Major Holdings
27th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTrading Update and Notice of Results
23rd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 202611:59 amRNSNotification of Transactions by a PDMR
13th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20265:17 pmRNSNotification of Major Holdings
24th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSNotification of Transactions by a PDMR and a PCA
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20268:13 amRNSShare Buyback Programme - Update
2nd Mar 20265:33 pmRNSTotal Voting Rights
26th Feb 20269:59 amRNSCorrection: Result of Annual General Meeting
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20265:19 pmRNSResult of AGM
25th Feb 20267:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.